Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018
Deborah Holtzman, Alice Asher, Sarah Schillie
American Journal of Public Health (2021) Vol. 111, Iss. 5, pp. 949-955
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The fourth wave of the US opioid epidemic and its implications for the rural US: A federal perspective
Richard A. Jenkins
Preventive Medicine (2021) Vol. 152, pp. 106541-106541
Closed Access | Times Cited: 78
Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study
Joseph Friedman, Daniela Abramovitz, Britt Skaathun, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 4, pp. 1109-1116
Closed Access | Times Cited: 6
Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
Kathleen Ward, Ayden I. Scheim, Jonathan Wang, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 3, pp. 100055-100055
Open Access | Times Cited: 22
Hepatitis C Virus Reinfection Among People Who Inject Drugs
Alain H. Litwin, Judith I. Tsui, Moonseong Heo, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2430024-e2430024
Open Access | Times Cited: 4
Prevalence and Correlates of Hepatitis C Viremia among People with HIV in the Direct-Acting Antiviral Era
Jimmy Ma, Robin M. Nance, Edward R. Cachay, et al.
Open Forum Infectious Diseases (2025)
Open Access
Sexual Transmission of Viral Hepatitis
Audrey R. Lloyd, Ricardo Franco
Infectious Disease Clinics of North America (2023) Vol. 37, Iss. 2, pp. 335-349
Closed Access | Times Cited: 9
Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies
José Manuel Ramos, Héctor Pinargote‐Celorio, Carmen de Mendoza, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 9, pp. 777-784
Open Access | Times Cited: 10
Evaluating the utility of a two‐assay serological algorithm for hepatitis C screening in a low prevalence population
Kai J. Rogers, Tracy S. Halvorson, Matthew D. Krasowski, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 7
Open Access | Times Cited: 4
Viral Infections of the Fetus and Newborn
Caleb Stokes, Ann J. Melvin
Elsevier eBooks (2023), pp. 450-486.e24
Closed Access | Times Cited: 4
Donor hepatitis C status is not associated with an increased risk of acute rejection in kidney transplantation
John C. Johnson, T Engebretsen, M.A. Mujtaba, et al.
Surgery in Practice and Science (2024) Vol. 16, pp. 100236-100236
Open Access | Times Cited: 1
Inverse probability weighting for selection bias in a Delaware community health center electronic medical record study of community deprivation and hepatitis C prevalence
Neal D. Goldstein, Deborah Kahal, Karla Testa, et al.
Annals of Epidemiology (2021) Vol. 60, pp. 1-7
Open Access | Times Cited: 10
Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs
Hansel Tookes, Asa Oxner, David P. Serota, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Hepatitis C active viremia over time in an ED‐based testing programme: Impact, disparities and surveillance tool
Lindy Reynolds, Ricardo Franco, Myles Prados, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 11, pp. 1026-1034
Closed Access | Times Cited: 5
HCV communication within ego-centric networks of men and women who inject drugs
Marisa Felsher, Karin E. Tobin, Mark Sulkowski, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109157-109157
Open Access | Times Cited: 6
Sustained Virologic Response Rates Before and After Removal of Sobriety Restriction for Hepatitis C Virus Treatment Access
Michelle T. Martin, Nicole Waring, Jasmine Forrest, et al.
Public Health Reports (2022) Vol. 138, Iss. 3, pp. 467-474
Closed Access | Times Cited: 4
Subspecialty physicians’ perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study
Erin Bredenberg, Catherine Callister, Ashley Dafoe, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access
Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United States
Eric Romo, Elyse Bianchet, Patrick F. Dowd, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1364-1364
Open Access
Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder
Jessica Frankeberger, Robert W. S. Coulter, Marian Jarlenski, et al.
Preventive Medicine (2024) Vol. 185, pp. 108057-108057
Closed Access
Effect of Self-efficacy Among PWID treated with Direct-Acting Antivirals on HCV Treatment Initiation, Duration, Completion, Adherence, and Cure
Snehal Lopes, Irene Pericot‐Valverde, James Edward Dotherow, et al.
Drug and Alcohol Dependence (2024) Vol. 262, pp. 111384-111384
Closed Access
Who declines “opt-out” HIV/HCV testing? Experience of an internal medicine resident continuity clinic serving a predominantly Black adult population in South Carolina.
Jodian Pinkney, Yao Tong, Susanne S. Hoeppner, et al.
Journal of the National Medical Association (2024) Vol. 116, Iss. 4, pp. 351-361
Open Access
Hepatitis C (HCV) among Black and Latino sexual minority men (SMM) in the Southern United States: Protocol of a prospective cohort epidemiological study
Adedotun Ogunbajo, Mitchell Brooks, Temitope Oke, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288129-e0288129
Open Access | Times Cited: 1
Hepatitis C Virus–HIV Coinfection in the United States Among People Who Inject Drugs: Data Needed for Ending Dual Epidemics
Anne C. Moorman, Danae Bixler, Eyasu H. Teshale, et al.
Public Health Reports (2023)
Open Access | Times Cited: 1
Coproduction of Low-Barrier Hepatitis C Virus and HIV Care for People Who Use Drugs in a Rural Community: Brief Qualitative Report
Shoshana H. Bardach, Amanda N. Perry, Elizabeth Eccles, et al.
Journal of Participatory Medicine (2023) Vol. 15, pp. e47395-e47395
Open Access | Times Cited: 1
National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status
George Pro, D. Andrew Tompkins, Soraya Azari, et al.
Drug and Alcohol Dependence (2021) Vol. 228, pp. 109092-109092
Closed Access | Times Cited: 2
Using Health Information Technology to Create Pathways for Hepatitis C Treatment and Cure in West Virginia.
Adam Baus, Andrea Calkins, Judith Feinberg, et al.
PubMed (2022) Vol. 19, Iss. 1, pp. 1j-1j
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top